In the Rising Stars of Separation Science interview feature we speak with early-career researchers about their passion for chromatography, their current research focus, and their plans for the future. The candidate must be within 5 years of receiving his or her PhD. If you would like to nominate a candidate for consideration, please can you supply the following information:
Information about the person submitting the nomination:
Submitter’s name:
Submitter’s email address:
Relationship to candidate:
Information about the candidate:
Candidate’s full name:
Current job title:
Organization:
Business address:
Year PhD was earned and from where (List degree, year, institution, and location):
Important: Candidates must be within 5 years of receiving their PhD in the year the award is presented.
Area(s) of focus of work:
Short summary, in 100–200 words, of the candidate’s achievements or contributions in the field of chromatography and why they deserve recognition:
Number of publications and total citations:
Key awards and honours:
Submission Instructions
To nominate a candidate, please email the following documents to Alasdair Matheson, editor-in-chief of The Column, at amatheson@mjhlifesciences.com :
Questions about the submission process should be directed to Alasdair Matheson, editor-in-chief of The Column, at amatheson@mjhlifesciences.com
GC Analysis Reveals PCB Accumulation in Antarctic Penguins and Krill
July 3rd 2025Researchers from the University of Murica (Murica, Spain), the Carlos III Health Institute (Madrid, Spain), and the University of Siena (Siena, Italy) evaluated the concentration of polychlorinated biphenyls (PCBs) in chinstrap penguins and krill from Deception Island (South Shetland Islands, Antarctica) to provide additional data of the PCB presence in Antarctica. To this end, 34 samples of different tissues corresponding to four adult specimens and six chicks were analyzed with gas chromatography.
FDA Grants Breakthrough Status to AI-Enhanced GC-MS Device for Bladder Cancer Detection
July 1st 2025A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas chromatography–mass spectrometry (GC–MS) and proprietary AI, generates real-time cancer risk scores.